Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Deloitte
Mallinckrodt
Moodys
UBS
Teva
Fuji
Johnson and Johnson
Julphar

Generated: November 20, 2018

DrugPatentWatch Database Preview

Siltuximab - Biologic Drug Details

« Back to Dashboard

Summary for siltuximab
Tradenames:1
Patents:8
Applicants:1
BLAs:1
Suppliers: see list1
Pharmacology for siltuximab
Mechanism of ActionInterleukin-6 Antagonists

US Patents for siltuximab

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 001 2014-04-23 ➤ Sign Up AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Sign Up RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 001 2014-04-23 ➤ Sign Up biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) ➤ Sign Up RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 001 2014-04-23 ➤ Sign Up biOasis Technologies, Inc. (Richmond, CA) ➤ Sign Up RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 001 2014-04-23 ➤ Sign Up CureVac AG (Tubingen, DE) ➤ Sign Up RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 001 2014-04-23 ➤ Sign Up Corning Incorporated (Corning, NY) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for siltuximab

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2014 00047 Denmark ➤ Sign Up PRODUCT NAME: SILTUXIMAB; REG. NO/DATE: EU/1/14/928/001-002 20140527
543 Luxembourg ➤ Sign Up PRODUCT NAME: SILTUXIMAB
14/048 Ireland ➤ Sign Up PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928/001-002 20140522
/2014 Austria ➤ Sign Up PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928 20140522
2014 00047 Denmark ➤ Sign Up PRODUCT NAME: SILTUXIMAB; REG. NO/DATE: EU/1/14/928/001-002 20140522
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Cantor Fitzgerald
Moodys
Chubb
Fish and Richardson
Farmers Insurance
Deloitte
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.